Literature DB >> 12032170

In vitro mimicry of essential fatty acid deficiency in human endothelial cells by TNFalpha impact of omega-3 versus omega-6 fatty acids.

Konstantin Mayer1, Reinhold Schmidt, Marion Muhly-Reinholz, Tina Bögeholz, Stephanie Gokorsch, Friedrich Grimminger, Werner Seeger.   

Abstract

Severe endothelial abnormalities are a prominent feature in sepsis with cytokines such as tumor necrosis factor (TNF)alpha being implicated in the pathogenesis. As mimic to inflammation, human umbilical vascular endothelial cells (HUVEC) were incubated with TNFalpha for 22 h, in the absence or presence of the omega-6 fatty acid (FA), arachidonic acid (AA), or the alternative omega-3 FA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). TNFalpha caused marked alterations in the PUFA profile and long chain PUFA content of total phospholipids (PL) decreased. In contrast, there was a compensatory increase in mead acid [MA, 20:3(omega-9)], the hallmark acid of the essential fatty acid deficiency (EFAD) syndrome. Corresponding changes were noted in phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and phosphatidylinositol, but not in the sphingomyelin fraction. Supplementation with AA, EPA, or DHA markedly increased the respective FA contents in the PL pools, suppressed the increase in MA, and resulted in a shift either toward further predominance of omega-6 or predominance of omega-3 FA. We conclude that short-term TNFalpha incubation of HUVEC causes an EFAD state hitherto only described for long-term malnutrition, and that endothelial cells are susceptible to differential influence by omega-3 versus omega-6 FA supplementation under these conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032170

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

1.  Synthetic and natural surfactant differentially modulate inflammation after meconium aspiration.

Authors:  Anne Hilgendorff; Daniel Rawer; Martin Doerner; Erol Tutdibi; Michael Ebsen; Reinhold Schmidt; Andreas Guenther; Ludwig Gortner; Irwin Reiss
Journal:  Intensive Care Med       Date:  2003-09-03       Impact factor: 17.440

2.  Albumin infusion for the critically ill--is it beneficial and, if so, why and how?

Authors:  Undurti N Das
Journal:  Crit Care       Date:  2015-03-30       Impact factor: 9.097

Review 3.  Combination of aspirin with essential fatty acids is superior to aspirin alone to prevent or ameliorate sepsis or ARDS.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2016-11-25       Impact factor: 3.876

4.  Impact of Unsaturated Fatty Acids on Cytokine-Driven Endothelial Cell Dysfunction.

Authors:  Simon Trommer; Anja Leimert; Michael Bucher; Julia Schumann
Journal:  Int J Mol Sci       Date:  2017-12-16       Impact factor: 5.923

5.  Impact of Polyunsaturated Fatty Acids on miRNA Profiles of Monocytes/Macrophages and Endothelial Cells-A Pilot Study.

Authors:  Claudia Roessler; Kevin Kuhlmann; Christine Hellwing; Anja Leimert; Julia Schumann
Journal:  Int J Mol Sci       Date:  2017-01-28       Impact factor: 5.923

6.  The Clinical Significance of Low Serum Arachidonic Acid in Sepsis Patients with Hypoalbuminemia.

Authors:  Junko Yamaguchi; Kosaku Kinoshita; Shingo Ihara; Makoto Furukawa; Atsushi Sakurai
Journal:  Intern Med       Date:  2018-02-28       Impact factor: 1.271

Review 7.  Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review.

Authors:  Undurti N Das
Journal:  J Adv Res       Date:  2018-12-21       Impact factor: 10.479

Review 8.  n-3 fatty acids, γ-linolenic acid, and antioxidants in sepsis.

Authors:  Undurti N Das
Journal:  Crit Care       Date:  2013-04-19       Impact factor: 9.097

9.  Inverse Relationship between Serum Lipoxin A4 Level and the Risk of Metabolic Syndrome in a Middle-Aged Chinese Population.

Authors:  Dan Yu; Zhiye Xu; Xueyao Yin; Fenping Zheng; Xihua Lin; Qianqian Pan; Hong Li
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

10.  Bioactive Lipids in COVID-19-Further Evidence.

Authors:  Undurti N Das
Journal:  Arch Med Res       Date:  2020-09-09       Impact factor: 2.235

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.